PRESS RELEASE published on 03/17/2026 at 06:59, 3 months 10 days ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets at Capital Markets Day in Göttingen, Germany Sartorius Strategy Capital Markets Day Growth Targets Biopharma Focus
BRIEF published on 03/16/2026 at 14:09, 3 months 10 days ago Sartorius dévoile une nouvelle plateforme pour améliorer la production de thérapie cellulaire Réduction Des Coûts Efficacité De Production Sartorius Innovation Plateforme De Thérapie Cellulaire Lancement D'Eveo
BRIEF published on 03/16/2026 at 14:09, 3 months 10 days ago Sartorius Unveils New Platform to Enhance Cell Therapy Production Cost Reduction Manufacturing Efficiency Cell Therapy Platform Eveo Launch Sartorius Innovation
PRESS RELEASE published on 03/16/2026 at 14:04, 3 months 10 days ago Sartorius launches next-generation platform to boost efficiency in cell therapy production Sartorius launches next-generation platform for efficient cell therapy production, enabling cost reduction and scalability. Integrated system addresses manufacturing challenges Sartorius Cell Therapy Production Efficiency Manufacturing Costs Eveo Platform
BRIEF published on 02/16/2026 at 10:41, 4 months 10 days ago Sartorius renforce ses objectifs climatiques grâce à la validation SBTi Sartorius Énergie Durable Émissions Nettes Nulles Objectifs Climatiques Objectifs Fondés Sur La Science
BRIEF published on 02/16/2026 at 10:41, 4 months 10 days ago Sartorius Enhances Climate Targets with SBTi Validation Net-zero Emissions Sartorius Sustainable Energy Science Based Targets Climate Targets
PRESS RELEASE published on 02/16/2026 at 10:36, 4 months 10 days ago Sartorius sharpens climate targets and receives validation from Science Based Targets initiative Sartorius sharpens climate targets with Science Based Targets initiative validation, aiming for net-zero emissions by 2045. Transitioning to renewable energy & sustainable practices Net-zero Emissions SBTi Sartorius Climate Targets Science-based
BRIEF published on 02/16/2026 at 09:13, 4 months 10 days ago Sartorius Publishes 2025 Annual Report Financial Calendar Annual Report Sartorius Bioprocess Solutions 2025 Revenue
BRIEF published on 02/16/2026 at 09:13, 4 months 10 days ago Sartorius publie son rapport annuel 2025 Calendrier Financier Sartorius Rapport Annuel Solutions De Bioprocédés Recettes De 2025
PRESS RELEASE published on 02/16/2026 at 09:08, 4 months 10 days ago Sartorius releases Annual Report for 2025 Sartorius releases Annual Report for 2025 showcasing financial performance and global presence in biopharmaceutical industry Financial Performance Annual Report Sartorius Biopharmaceutical 2025
Published on 06/27/2026 at 01:40, 7 hours 10 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 8 hours 50 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 9 hours 50 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 10 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 10 hours 35 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 8 hours 45 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 8 hours 46 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 9 hours 14 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 9 hours 14 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 9 hours 23 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
